Aflac Incorporated

Alpha Score of 41 reflects weak overall profile with moderate momentum, poor value, weak quality. Based on 3 of 4 signals — score is capped at 90 until remaining data ingests.

Aflac Inc. is a leading supplemental health and life insurance provider operating primarily in the United States and Japan. The company offers a diverse range of products designed to cover out-of-pocket expenses not typically addressed by primary health plans, including cancer insurance, accident coverage, critical illness policies, disability insurance, dental and vision plans, hospital indemnity, long-term care, medical, nursing care, whole life, and child endowment insurance. Aflac Inc. structures its operations into two key segments: Aflac Japan, which generates the majority of revenue through individual medical and cancer policies distributed via door-to-door sales forces, banks, and financial institutions; and Aflac U.S., focusing on individual and employer-sponsored group policies sold through independent agents, brokers, payroll deduction systems, and digital channels. This dual-market presence enables broad accessibility to consumers at workplaces and beyond, complementing existing coverage for accidents, illnesses, and hospital stays. Founded in 1955 and headquartered in Columbus, Georgia, Aflac Inc. plays a vital role in the global insurance landscape by emphasizing supplemental protection tailored to personal and professional needs.